KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sarepta Therapeutics (SRPT) Non-Current Assets (2016 - 2025)

Sarepta Therapeutics has reported Non-Current Assets over the past 16 years, most recently at $811.8 million for Q4 2025.

  • For Q4 2025, Non-Current Assets fell 8.76% year-over-year to $811.8 million; the TTM value through Dec 2025 reached $3.6 billion, up 10.11%, while the annual FY2025 figure was $811.8 million, 8.76% down from the prior year.
  • Non-Current Assets for Q4 2025 was $811.8 million at Sarepta Therapeutics, up from $771.1 million in the prior quarter.
  • Over five years, Non-Current Assets peaked at $1.0 billion in Q1 2025 and troughed at $476.9 million in Q3 2021.
  • A 5-year average of $683.7 million and a median of $656.1 million in 2023 define the central range for Non-Current Assets.
  • Biggest five-year swings in Non-Current Assets: surged 38.81% in 2024 and later fell 15.68% in 2025.
  • Year by year, Non-Current Assets stood at $543.9 million in 2021, then rose by 4.9% to $570.5 million in 2022, then grew by 20.11% to $685.2 million in 2023, then increased by 29.84% to $889.7 million in 2024, then dropped by 8.76% to $811.8 million in 2025.
  • Business Quant data shows Non-Current Assets for SRPT at $811.8 million in Q4 2025, $771.1 million in Q3 2025, and $1.0 billion in Q2 2025.